Geneos Wealth Management’s Calamos Laddered S&P 500 Structured Alt Protection ETF CPSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
5,750
+1,650
+40% +$45.8K ﹤0.01% 1069
2026
Q1
$112K Hold
4,100
﹤0.01% 1140
2025
Q4
$112K Hold
4,100
﹤0.01% 1118
2025
Q3
$110K Buy
4,100
+3,700
+925% +$98.4K ﹤0.01% 1089
2025
Q2
$10.5K Buy
+400
New +$10.3K ﹤0.01% 2308

Other funds holding CPSL

Geneos Wealth Management's CPSL Position: Q2 2026 in Review

Geneos Wealth Management increased its Calamos Laddered S&P 500 Structured Alt Protection ETF (CPSL) stake by 40% in Q2 2026, buying an estimated $45.8K and bringing the position to 5,750 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Geneos Wealth Management first reported a position in CPSL in Q2 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold CPSL as of Q2 2026.

  • Geneos Wealth Management held 5,750 shares of Calamos Laddered S&P 500 Structured Alt Protection ETF worth $161K as of Q2 2026.
  • Geneos Wealth Management bought 1,650 Calamos Laddered S&P 500 Structured Alt Protection ETF shares in Q2 2026, an estimated $45.8K.
  • Calamos Laddered S&P 500 Structured Alt Protection ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1069 holding.
  • Geneos Wealth Management first reported a position in Calamos Laddered S&P 500 Structured Alt Protection ETF in Q2 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Calamos Laddered S&P 500 Structured Alt Protection ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.